Conference abstractPublished 2018
Non-cultured epithelial cells in platelet-rich plasma for the resurfacing of massive and chronic fullthickness burns: A case series
Inkosi Albert Luthuli Central Hospital, South Africa
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
We describe the use of a combination of platelet-rich fibrin and spray-on skin for 15 patients with massive burns and five patients with chronic burn wounds. A fast, complete graft take was noted in all cases. The coverage of massive burns (i.e. more than 40% TBSA) is a challenge. As about 80% of the skin can be used as possible donor sites, the area to be grafted in massive burns often exceeds the available donor skin. A number if strategies are available to deal with this situation. Re-harvesting from a previously used donor sites is possible, but requires a regeneration period of 2-3 weeks. Wide meshing (to a ratio of 1: 4 or more) and the MEEK technique have been proposed to make better use of available skin, but also require time for re-epithelialization of the interstices between the grafted areas, during which time these areas need to be protected from dehydration and microbial colonization. Cultured epithelial grafts also take about 3 weeks to be cultured, and although recently an affordable technique has been developed, long-term results remain poor. In our environment, cadaver skin is rarely offered, and the high rates of HIV/AIDS preclude the use of amniotic membrane as a temporizing dressing. Spray-on skin cells (suspended epithelial cells) are an alternative for these patients. Two techniques are in the manner in which the skin cells are separated, i.e. either enzymatically (using trypsin, ReCell®) or mechanically (Rigenera®). Problem with the use of sprayon cells has been that when the cells are suspended in a low-viscosity solution such as normal saline, they tend to be spread unevenly over the surface to be grafted, while there may be a significant graft loss, as cells float off the wound with the medium and end up on the towels. We recently developed a technique in which spray-on cells are combined with platelet-rich fibrin, in order to increase the yield of grafted cells in patients in which this technique is used with the Vivostat® system (Vivostat A/S, Lillerød, Denmark). We feel that the results of PRF/Spray-on skin are sufficiently promising to warrant setting up a randomized trial and setting one up.
Subjects
EngineeringAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Regenerative Medicine
- SubjectEngineering
- BylineArticles whose byline prints “Alessandro Andreone”
